The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

President Donald Trump’s administration has placed a freeze on information being released from government health agencies. According to a memo obtained by the Associated Press, the “immediate pause” ...

Findings show accumulation of neuronal injury and functional decline suggesting that changes in gonadal hormones may be associated with changes in functional and biological markers in MS.

Researchers sought to examine annual hyperlipidemia-related cardiovascular disease mortality trends in the United States.

The majority of working-age patients with post-acute sequelae of COVID-19/post-COVID-19 syndrome (PCS) do not recover in the second year of their illness, accor ...

Weather-related disasters may dominate news coverage related to climate change, but hospitals are also seeing more patients who require care due to extreme temperatures, drought, poor air quality, and ...

President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

The prescription of high dose was associated with an increased risk of TD, and the highest risk was observed in the group receiving >300 mg/day.

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.